In The News
Google maintains stronghold on search despite regulatory changes: ACCC report
Court won’t give Hanson discount on costs in Greens senator’s case
Judge boots Queensland energy class action, says ‘profit maximisation’ not unlawful
Thomson Geer poaches IP, tech team from HopgoodGanim
NAB super trustee free to use $165M fees ‘as it saw fit’, class action judge says
Coles, Woolworths say price increases were genuine, and so were the discounts
Dentons says former partner’s equity prospects curtailed by own conduct
Start-up denies ex-Fortescue employees developed green iron on company dime
In class action defence, Toyota says ‘defeat device’ used to protect engines
Hamilton Locke loses challenge to Sydney law firm’s trade mark
Please login to bookmarkClose

Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a biosimilar of the blockbuster arthritis drug in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au